CDKN2A and pancreatic neoplasm: Additionally, high CA125 levels in serum positively correlated with genetic alterations in “driver” genes, and especially with co-alteration of CDKN2A/p16, TP53, and SMAD4/DPC4, in pancreatic cancer specimens.